Clinical Trials Directory

Trials / Unknown

UnknownNCT01819740

Analysis of a New Biomarker for Prostate Cancer Diagnosis

Status
Unknown
Phase
Study type
Observational
Enrollment
28 (estimated)
Sponsor
Corporacion Parc Tauli · Academic / Other
Sex
Male
Age
45 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The aim of our study is to determine if the levels of the "HEM" substance in seminal plasma are associated with the presence of prostate cancer in transrectal prostate biopsy.

Conditions

Interventions

TypeNameDescription
OTHERdetermine the levels of the "HEM" substance in seminal plasma

Timeline

Start date
2013-04-01
Primary completion
2013-04-01
First posted
2013-03-28
Last updated
2013-03-28

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT01819740. Inclusion in this directory is not an endorsement.

Analysis of a New Biomarker for Prostate Cancer Diagnosis (NCT01819740) · Clinical Trials Directory